Aidigong Maternal & Child Health Ltd
HKEX:286
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (3.6), the stock would be worth HK$1.31 (0% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.6 | HK$1.31 |
0%
|
| 3-Year Average | 3.6 | HK$1.31 |
0%
|
| 5-Year Average | 4 | HK$1.46 |
+11%
|
| Industry Average | 16.5 | HK$6.04 |
+361%
|
| Country Average | 13.9 | HK$5.08 |
+288%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| HK |
A
|
Aidigong Maternal & Child Health Ltd
HKEX:286
|
251.8m HKD | 3.6 | -1.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
104.3B USD | 12.3 | 59 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 12.6 | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
74.5B USD | 0 | 12.5 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | -25.1 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 13.9 | 22.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.4B USD | 23.7 | 21 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21B USD | 627.8 | 24 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 6.7 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 69.1 | -27.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 6 | 13.9 |
Market Distribution
| Min | 0.3 |
| 30th Percentile | 7.1 |
| Median | 13.9 |
| 70th Percentile | 22.8 |
| Max | 11 983 |
Other Multiples
Aidigong Maternal & Child Health Ltd
Glance View
Aidigong Maternal & Child Health Ltd. operates as an investment holding company. The firm operates through two segments. The Health Industry segment is engaged in the natural health food, medical anti-aging and health preservation base, medical and healthcare industry investment management business. The Investment and Finance segment is engaged in the investment and financing.
